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ABSTRACT
The teaching of performance enhancing drugs in U.S. schools and colleges of pharmacy
is necessary to better help patients who are athletes especially those who compete in
high-level athletics such as the Olympics or the National Collegiate Athletic Association
(NCAA). There is no master list for banned substances, they differ for each organization
and have many exceptions. Pharmacists can play a key role in preventing unintentional
disqualifications of athletes as there are many medications considered performance
enhancing drugs including some supplements and stimulants. For example, commonly
used cold medications may contain pseudoephedrine hydrochloride, a banned substance
in the world of athletics, with both the athlete and the pharmacist unaware of its status.
The objectives of the study were to determine whether a school or college of pharmacy
offers any amount of teaching about performance enhancing drugs, the extent of which
the topic is incorporated into the curriculum, and if the school or college will offer related
content in the future if not currently. Another objective of the study was to determine
whether the institutions that the schools and colleges of pharmacy are associated with
have intercollegiate athletic programs and whether they offer PharmD curriculum that
includes performance enhancing drugs. A final objective of the study was to determine
whether different regions of the United States have influence on whether schools or
colleges of pharmacy offer PharmD curriculum that includes performance enhancing
drugs. A descriptive, cross-sectional study was used to collect data from 20 different
schools and colleges of pharmacy. The respondents reported whether their institution
currently offers a course about or with content relating to performance enhancing drugs.
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Follow-up questions about the extent of the course in its information and placement in the
curriculum were also asked. Most respondents reported that their institution does not
have a course that discusses performance enhancing drugs, nor will they have one in the
immediate future. This could be improved if the discussion about pharmacist involvement
in sports pharmacy increases and its benefits become more widely known and
recognized.
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BACKGROUND
History and Definitions
Ergogenic is a term derived from the Greek words ergon (work) and gennan (to
produce) and means a strategy that enhances work capacity. There are five categories of
sports ergogenics: nutritional aids, pharmacological aids, physiological aids,
psychological aids, and mechanical or biomechanical aids. Performance enhancing drugs
are pharmacological sports ergogenics (Guimaraes-Ferreira et al. 29). They are
substances used to improve athletic performance and some examples include anabolic
steroids, human growth hormones, and erythropoietin [(blood doping)] (“PerformanceEnhancing Drug”). They can be grouped into broad categories including increasing
concentration and alertness; boosting strength, power, and explosiveness; increasing the
oxygen-carrying capacity of blood; enhancing recovery, recuperation, and reconstitution
of the athlete; and improving inflammation and pain (Gaffney 151).
Performance enhancing drugs have been used since ancient times. Norse warriors
ate hallucinogenic mushrooms before going into battle (Sommers 106). Ancient Olympic
athletes ate sheep testicles to increase their testosterone levels (Miller 296). The Greek
physician Galen was recorded prescribing “the rear hooves of an Abyssinian ass, ground
up, boiled in oil, and flavored with rose hips and rose petals” in order to improve a
person’s performance (Grasso et al. 161). It is known that athletes used substances from
plants including hemp, kava, opium, ginseng root, “ma huang” (ephedra), Strychnos nux
vomica (strychnine tree), and hallucinogenic mushrooms (Miller 296). However, there
are many consequences of performance enhancing drugs including irreversible
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androgenic/anabolic effects, toxic hepatitis, withdrawal, dependence, body dysmorphic
disorder, depression, aggression, the unmasking or acceleration of cancer growth,
diabetes mellitus, dyslipidemias, cardiomyopathy, and nephrotoxicity (Wick). Some early
modern performance enhancing drug usage includes a Welsh cyclist, Arthur Linton, who
died during a race in 1886. He is believed to have taken trimethyl, a stimulant. In 1889, a
French physician injected himself with extracts from dog and guinea pig testicular fluid
because he believed it gave him more energy (“A Timeline of Performance-Enhancing
Drugs in Sports”). Later in 1904, Thomas Hicks overdosed on brandy with strychnine
and won gold (Miller 296). During World War II, American, British, German, and
Japanese armed forces took amphetamines to counteract fatigue, elevate mood, and
increase endurance leading to their use in sports in the 1950s (“Historical Timeline:
History of Performance Enhancing Drugs in Sports”).
Anabolic steroids are normally groups of synthetic hormones, which are derived
from testosterone, and used medically to increase tissue growth. They are abused by
athletes to increase endurance and the size and strength of muscles (“Anabolic Steroid”).
They also may increase aggressiveness of the athlete both on and off the field (Gaffney
153). They are the most commonly abused substances (Wick). Another type of anabolic
steroids are designer steroids which are very dangerous and designed to be undetectable
by current drug tests (Mayo Clinic Staff, “Performance-Enhancing Drugs: Know the
Risks”). In 1958, the U.S. Food and Drug Administration (FDA) approved the first
anabolic steroid for sale in the United States (“Historical Timeline: History of
Performance Enhancing Drugs in Sports”). In the 1976 Olympics in Montreal, Canada,
the East German Olympic team used steroids and evaded detection through the use of
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state plan theme 14-25. State plan theme 14-25 was a state-sponsored doping program
under East Germany’s elite sports federation headed by Manfred Ewald and monitored by
the Ministry of State Security (Stasi). Girls as young as 12 were regularly given untested
steroids and male hormones as part of their training with side-effects including male-type
hair growth, deepened voices, liver disease, heart disease, depression, infertility,
miscarriages, and death. East German athletes were given Oral-Turninabol or O-T which
was an anabolic steroid derived from testosterone. O-T and other anabolic steroids are
known to increase muscle mass and quicken recovery time (“Doping for Gold”).
Human growth hormone, a peptide hormone, is defined as naturally occurring or
genetically engineered to treat children with growth hormone deficiencies. It has also
been used by athletes to increase muscle mass (“Human Growth Hormone”). It is
produced by the pituitary gland and can help regulate body composition, body fluids,
muscle and bone growth, sugar and fat metabolism, and possibly heart function (Khatri).
It can also increase exercise capacity, bone density, and muscle mass, but decrease body
fat. However, there are multiple risks such as increased carpal tunnel syndrome and
insulin resistance, Type 2 diabetes, edema, joint and muscle pain, gynecomastia, and
increased risk of certain cancers (Mayo Clinic Staff, “Human Growth Hormone (HGH):
Does It Slow Aging?”). When produced synthetically it is an active ingredient in many
prescription drugs and other products. It was developed in 1985 and approved by the
FDA for specific uses in children and adults. Some of those uses include Turner’s
syndrome, Prader-Willi syndrome, chronic kidney disease, HGH deficiency or
insufficiency, children born small for gestational age, short bowl syndrome, and musclewasting disease associated with HIV/AIDS. While used by athletes to improve muscle
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mass, human growth hormone’s effect on athletic performance is unknown (Khatri).
Androstenedione (andro) is a hormone produced by the adrenal glands, ovaries,
and testes. It is converted to testosterone and a form of estrogen (estradiol) in both men
and women. Andro is legally available as a prescription and is a controlled substance.
Contrary to scientific studies, manufacturers and bodybuilding magazines claim andro
allows athletes to train harder and recover faster. Andro can cause acne, diminished
sperm production, shrinking of the testicles, and enlargement of the breasts in men. In
women, it can cause acne and maculation. Andro can also cause damage to the heart and
blood vessels which increases the risk for heart attack and stroke (Mayo Clinic Staff,
“Performance-Enhancing Drugs: Know the Risks”).
Doping is illegal and defined as when a substance or technique is used to improve
athletic performance. Some examples are anabolic steroids and erythropoietin or blood
doping (“Doping”). Doping comes from the 19th century Dutch word dop which was used
to describe a South African drink. That drink consisted of an extract of cola nuts,
xanthines (found in caffeine), and alcohol. The drink was intended to improve endurance
(Grasso et al. 161). The objectives of doping include increasing strength and endurance,
aiding in workout/injury recovery, altering intensity and aggression, sharpening focus and
concentration, combatting exhaustion and fatigue, reducing weight/body fat, relieving
aches and pains, and increasing muscle mass and/or oxygenation. Doping’s payoff is
increased oxygen delivery to active muscles which includes an effective technique to
increase the number of red blood cells (Wick). Erythropoietin is a type of hormone that is
used to treat anemia in those with severe kidney disease. It causes the increase of red
blood cells and hemoglobin. Erythropoietin also increases the movement of oxygen to the
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muscles and can increase the risk of stroke, heart attack, and blockage in an artery in the
lungs. Epoetin, a synthetic form of erythropoietin, is commonly used by endurance
athletes (Mayo Clinic Staff, “Performance-Enhancing Drugs: Know the Risks”).
Performance enhancing supplements are taken instead of or in addition to
performance enhancing drugs. Many nutritional supplements are available over-thecounter as powders or pills (Mayo Clinic Staff, “Performance-Enhancing Drugs: Know
the Risks”). They are often included alongside performance enhancing drugs in resources
such as “Performance-Enhancing Drugs: Know the Risks” written by Mayo Clinic Staff
and “Care of the Young Athlete Patient Handouts - Performance-Enhancing
Supplements” by the American Academy of Pediatrics. In both resources, for example,
anabolic steroids are discussed near creatine and stimulants. For the purpose of this study
the term performance enhancing drugs will mainly be used to encompass the supplements
and stimulants as they are at times on banned substance lists as well.
Creatine monohydrate is a nutritional supplement that is popular among athletes.
It is a naturally occurring compound which is produced by the body to help the muscles
release energy. Scientific research dictates that it may give athletes small gains in shortterm bursts of power. Some possible side effects are stomach cramps, muscle cramps, and
weight gain. Weight gain is more likely to be water retention than increasing muscle
mass (Mayo Clinic Staff, “Performance-Enhancing Drugs: Know the Risks”). It is also
available over-the-counter in different forms and not screened or banned by WADA, the
IOC, or the NCAA. However, these forms are not regulated by the U.S. Food and Drug
Administration (FDA) and may contain other substances and/or different amounts of the
substance (Butts et al.).
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Performance enhancing stimulants are used to stimulate the central nervous
system and increase heart rate and blood pressure. Stimulants can increase physical
performance by improving endurance, reducing fatigue, suppressing appetite, and
increasing alertness and aggressiveness. They also include caffeine and amphetamines.
Many cold medicines have the stimulants ephedrine or pseudoephedrine hydrochloride.
Energy drinks contain high doses of caffeine and other stimulants. Some risks include
nervousness, insomnia, dehydration, heatstroke, addiction or tolerance, heart problems,
tremors, and stroke. Also cocaine and methamphetamine are stimulants (Mayo Clinic
Staff, “Performance-Enhancing Drugs: Know the Risks”).
Diuretics are used by athletes to help pass drug tests. They are drugs that change
the body’s natural balance of fluids and salts (electrolytes). They can lead to dehydration.
The loss of water decreases the athlete’s weight and is used to help pass drug tests as the
urine is diluted. This is sometimes called a “masking” agent. Some risks include
dehydration, muscle cramps, dizziness, potassium deficiency, drops in blood pressure,
loss of coordination and balance, and death (Mayo Clinic Staff, “Performance-Enhancing
Drugs: Know the Risks”).
History of Banning and Testing for Drugs
In 1928, the International Amatueur Athletic Federation (IAAF) was the first
international sporting federation to ban doping by athletes. In 1967, The International
Olympic Committee (IOC) established a medical commission to fight doping. There are
three guiding principles: protection of the health of the athletes, respect for the medical
and sport ethics, and equality for the competing athletes (“Historical Timeline: History of
Performance Enhancing Drugs in Sports”). The main goals of the IOC are managing
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health care and doping control services during the Olympic and Youth Games, giving a
factual education to athletes and their entourage, developing and promoting the use of
ethical standards in sports science and medicine, using new technologies to improve
athletes’ health and prevent potential damaging effects, and promoting health and
physical activity for the entire population (“Medical and Scientific Commission”). In
1967, the IOC Medical Commission released a list of banned substances which had
stimulants and narcotic analgesics including sympathomimetic amines, psychomotor
stimulants, and miscellaneous central nervous system stimulants including alcohol. In the
1968 Olympic Games in Mexico City, Mexico, the IOC implemented a regime of
preliminary drug testing. It was also the first time an athlete was disqualified for drug use
when Hans-Gunnar Lilienvall, a member of the Swedish modern pentathlon team, caused
the entire Swedish men’s team to forfeit their bronze medals when his blood alcohol level
was tested to be higher than the allowable limit. In the 1972 Olympic Games in Munich,
Germany, the first comprehensive testing at the international competition level took place
for narcotics and stimulants (“Historical Timeline: History of Performance Enhancing
Drugs in Sports”). In 1975, anabolic steroids were added to the IOC’s banned substance
list (“A Timeline of Performance-Enhancing Drugs in Sports”). In 1976, at the Olympic
Games in Montreal, Canada, anabolic steroids were tested for the first time (“Historical
Timeline: History of Performance Enhancing Drugs in Sports”). In the 1988 Olympic
Games in Seoul, South Korea, Ben Johnson, a Jamaican born Canadian sprinter won gold
against Carl Lewis, but was stripped of his medal three days later after he tested positive
for anabolic steroids (“Ben Johnson Wins Gold, Temporarily”). Also in 1988, on
November 18, 1988, President Ronald Regan signed the Anti-Drug Abuse Act of 1988
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which outlawed the sale of steroids for non-medical purposes. On October 5, 1990,
Congress passed the Anabolic Steroids Control Act which classified steroids in the same
legal class as amphetamines, methamphetamines, opium, and morphine. On June 7, 1991,
Major League Baseball banned all possession, sale, or use of any illegal drug or
controlled substance including steroids. In 1999, the World Anti-Doping Association
(WADA) was established and in 2000, the United States Anti-Doping Agency (USADA)
was established (“Historical Timeline: History of Performance Enhancing Drugs in
Sports”). WADA is an international independent agency that involves scientific research,
education, development of anti-doping capacities, and monitoring of anti-doping
programs around the world (Guimaraes-Ferreira et al. 29). In 2002, the first reported
designer steroid was found in an athlete’s urine and in 2003, gene doping was banned by
WADA (“Historical Timeline: History of Performance Enhancing Drugs in Sports”).
WADA developed the World Anti-Doping Code in 2003. The World Anti-Doping
Program in sports is based on this Code, a document that “advance[s] the anti-doping
effort through universal harmonization of core anti-doping elements” (World AntiDoping Agency). The code is both specific and flexible depending on the principle and
focus. The World Anti-Doping Code and the World Anti-Doping Program protect the
right of athletes to participate in doping-free sport and encourages health, fairness, and
equality worldwide in athletics. It also attempts to standardize anti-doping programs that
have effectiveness and are harmoniously coordinated at international and national levels
in the efforts of anti-doping programs. These programs help to detect, deter, and prevent
doping (World Anti-Doping Agency). However, there is no universal list of banned
substances (Ross) and in 2004 the IOC gave WADA control of the prohibited substances
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list (“Historical Timeline: History of Performance Enhancing Drugs in Sports”). There
are instead many databases. The NCAA has its own list for college students (Ross) which
is published annually (Wick). The Olympics and the National Basketball Association
(NBA) have their own lists. The lists are not identical and have many differences. If a
student athlete wants to attend the Olympics, they must abide by both the NCAA and the
Olympics banned substances lists. There are also grey/contradicting circumstances. For
example, during the Olympics some drugs are banned at all times, while others are
banned only during the competition (Ross). The National Center for Drug Free Sport
offers drug-use prevention services for athletic organizations. The Resource Exchange
Center (REC) educates athletes and other supporting athletic staff on dietary supplement
labels and assigns risk levels based on where ingredients fall in some banned drug
classes. Most banned or not-banned substances are in the database (Shaman). It is
believed 6/10 athletes use and test positive for drugs/anabolic steroids/banned substances
(Wick).
Pharmacists in Sports: General Information and History
The Statement of Professional Standards: “The Role of the Pharmacist in the
Fight Against Doping in Sport” was adopted by the International Pharmaceutical
Federation (FIP) in 2005 and details a need for pharmacists to be involved in sports
medicine. In 2014, it was transformed into the FIP Guidelines which refers to the World
Anti-Doping Agency (WADA) Anti-Doping Code. The guidelines also discuss
recommendations about doping control in regard to pharmacists, governments, and
pharmaceutical associations (Hooper et al.). Pharmacists are recommended by WADA to
remain up-to-date with the contents of the WADA Code, assist athletes to recognize if the
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use of a substance may be banned or restricted in their sport, and provide information to
athletes about the risks and benefits of nutritional supplements (Hooper et al.), such as
creatine monohydrate (Guimaraes-Ferreira et al. 32), as many of those supplements
contain banned substances in violation of the WADA Code or specific sports-governing
parties (Hooper et al.). Sports pharmacy also includes providing drug-information and
education services to athletes, coaches, and supporters. Pharmacists could identify,
manage, and monitor athletes actively seeking performance enhancing supplements. The
prevention and control of doping has many aspects including drug-use for therapeutics
and performance enhancement. Pharmacist involvement requires knowledge and
interpretation of banned substance lists, advising on dietary supplements, over-thecounter (OTC) and prescription medicines and products, and tailored formulary
development, inventory control and record keeping. Pharmacists have also been involved
in drug-testing (Hooper et al.).
In Japan, the Japan Pharmaceutical Association and the Japan Anti-Doping
Agency (JADA) created an initiative in 2009 that promotes anti-doping by using the
knowledge of many different health professions. Pharmacists can become certified as
“Sports Pharmacists” by JADA and in 2014 there were 6000 certified (Hooper et al.).
In 2012 at the London Olympic Games, more than 100 volunteer pharmacists and
pharmacy technicians were at the polyclinics within the Athlete Villages. The pharmacy
services were provided in accordance to United Kingdom Standards. Pharmacists wrote
and reviewed Olympic and Paralympic drug formularies and delivered international drug
information service to the prescribers at the Games. Pharmacists also provided services to
non-athletes at the Games through the Pharmacy Minor Ailments Scheme to decrease the
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workload on other health professionals. The Center for Pharmacy Postgraduate Education
(CPPE) created a 12-week online e-learning program titled ‘The Use of Drugs in Sport: A
Healthcare Professional’s Perspective’ for the 2012 Olympic Games. It had three
sections: doping and anti-doping in sport, pharmacy services and support in sport and
fitness, and medical services at international sporting events. Although no longer
available, this program was a pre-requisite for pharmacy volunteers and was available on
the CPPE website for all pharmacists, pharmacy technicians, and health professionals in
the United Kingdom. In 2018, a similar program was created for the Commonwealth
Games at the Gold Coast in Australia (Hooper et al.).
There is limited opportunity for education in sports pharmacy in undergraduate
curriculum and postgraduate education. Exclusion of sports pharmacy in undergraduate
curriculum is shown in one study to have only 6% of pharmacists recall being taught
about doping control while in school and 26% in another study. However, 90% of
pharmacy students in Qatar were for incorporating sports pharmacy into undergraduate
curriculum. Pharmacists are interested in short post-graduate/professional development
courses that are either online or face-to-face in sports pharmacy, but most are unable to
attend them due to limited opportunity (Hooper et al.).
Need for Pharmacists in Sports
While many banned substances are unnecessary and even harmful to athletes,
many drugs that are banned across the different organizations are everyday and/or
medically necessary prescriptions. This includes Tylenol and asthma inhalers. There are
also legitimate medical purposes as to why an athlete may need to take banned substances
including hypertension, asthma, and hormone replacement therapy. In the 2000
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Olympics, Andreea Mädälina Räducan, a Romanian gymnast, had pseudoephedrine in
her system because she had a cold. Pseudoephedrine is a banned substance in the
Olympics and she was stripped of her medal (Ross). Some athletes are even unaware that
they are ingesting banned substances in dietary supplements because they are not
typically listed on the label (Shaman). In 2006, a U.S. skeleton racer was banned for the
use of hair growth medicine that contained Finasteride which was only on the banned
substances list from 2005-2009 (“Historical Timeline: History of Performance Enhancing
Drugs in Sports”).
Pharmacists provide healthcare to patients in sporting culture in noncompetitive/individual fitness and local club sports and they provide advice for elite
athletes competing in the Olympic Games or in other international areas. There are roles
in doping and anti-doping, injury management and prevention, and first aid. A systematic
review on sports pharmacy has not been performed in the past although there are some
guidelines for pharmacists about management of common sports injuries and counseling
or advising athletes. Pharmacists know about prescription medications, over-the-counter
medications, and many other drugs. They know their side effects, contraindications,
indications, etc. However, many interact with athletes on a very limited basis, outside of
their athletic facilities, and have limited knowledge about sports-related medicine and
drugs making it difficult at times to give evidence-based advice to athletes, coaches and
managers, clubs and organizations, family members, and supporters. This is in-part due to
the fact that there is a lack of educational opportunities for pharmacists and pharmacy
students to learn and practice sports pharmacy. Most pharmacists would also not have
knowledge about the banned substances lists and the substances on them or the
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confidence to discuss doping and/or licit and illicit drugs with an athlete (Hooper et al.).
Ambrose (2008) and Doty et al. (2015) showed that increasing the amount of education
and opportunities to practice skills in sports pharmacy may increase pharmacist
knowledge and confidence (qtd. in Hooper et al.). Most collegiate and professional sports
teams employ athletic trainers and physicians, but few have a pharmacist on staff (“Drugs
and Sports: New Niche for Pharmacy”). Pharmacists were able to track usage through
medication management software tools by the late 1990s. In the mid-2000s, steroid and
doping controversies among baseball players, professional cyclists, and Olympic athletes
provided incentive for sports teams and medical professionals to track and monitor drug
usage (Shaman). It was described how “many athletes know the pharmacokinetics and
pharmacology of the drugs they take better than a third-year pharmacy student does”
(Wick). Pharmacists need to be more involved in doping prevention and monitoring
athletes with legitimate medical reasons to why they are ingesting banned substances.
They need to be able to counsel athletes about dietary supplements that are banned,
contaminated, or suspicious. Pharmacists need knowledge, background, or insight about
banned substance lists. They need to encourage athletes to research or to contact the
associations involved, and they need to encourage athletes to apply for medically
necessary exceptions (Ross). Most athletes purchase supplements online without
consulting a health professional. Pharmacists are consulted only between 2% and 35% of
the time. Athletes also discuss doping with other players, coaches, team managers, and
the internet rather than a health professional which is a major part of the problem
(Hooper et al.).
As of 2018, there are 314,300 pharmacist jobs in the United States (“Pharmacists:
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Occupational Outlook Handbook”), 143 U.S. schools and colleges of pharmacy (one of
which is international based) with accredited (full or candidate status) and 1 with
precandidate status (144 total institutions) (“Programs by State”) are institutional
members of AACP (“AACP Institutional Membership”), and 112 of those institutions
have a pharmacy school or college and intercollegiate athletic programs. Medical
campuses or graduate institutes of a larger university, college, or consortium (i.e.
University of Arkansas for Medical Sciences and University of Arkansas) are considered
separate institutions in this regard. Pharmacists are needed in the world of athletics, the
majority have attended institutions with athletics programs, and may not know an asthma
inhaler can disqualify an athlete (Ross).
Curriculum within Pharmacy Schools and Colleges
The purpose of accreditation is quality assurance. In pharmacy, it allows
practitioners to create requirements of schools and colleges so that professional students
are prepared to enter the profession. The Accreditation Council for Pharmacy Education
(ACPE) provides this accreditation to PharmD Programs (“PharmD Program
Accreditation”). From basic research, the ACPE does not require PharmD programs to
teach students out right about performance enhancing drugs in curricular didactic courses.
The ACPE requires that schools and colleges of pharmacy provide a broad range of
elective courses. This is in order for students to be able to learn about career options,
cultivate personal interest, and achieve curricular outcomes (Santee et al.). The ACPE
does not mandate the specific number of elective credits within PharmD curriculum
though most programs have between 6 and 15 hours of didactic elective courses and 1 to
4 elective APPEs (Accreditation Council for Pharmacy Education 7-8).
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Study Objectives
Due to the lack of literature and easily accessible information about the amount of
teaching schools and colleges of pharmacy across the United States provide about
performance enhancing drugs, the objectives of this study are to:
1. To determine whether a school or college of pharmacy offers any amount of
teaching about performance enhancing drugs.
2. To determine the extent performance enhancing drugs are incorporated into the
curriculum of a school or college of pharmacy.
3. To determine whether a school or college of pharmacy, that currently does not
offer a course that includes teaching about performance enhancing drugs, will in
the future.
4. To determine if different regions of the United States offer pharmacy curricula
that includes performance enhancing drugs.
5. To determine whether the institutions that have schools and colleges of pharmacy
have athletic programs and whether or not they offer a curriculum that includes
performance enhancing drugs.
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METHODS
Design
This study employed a cross-sectional, descriptive design to assess study
objectives using a self-administered electronic survey that was sent to U.S. schools and
colleges of pharmacy.
Sample
A list of curriculum coordinators for United States schools and colleges of
pharmacy (study participants) were obtained and purchased from the American
Association of Colleges of Pharmacy (AACP) in June of 2019. The list included 198
curriculum coordinators. There were 144 schools of pharmacy as of July 2019
(“Academic Pharmacy’s Vital Statistics”), which indicates there is likely more than one
curriculum coordinator designated for some schools or colleges of pharmacy.
Survey Instrument
The first question in the survey instrument asked the participant what school or
college of pharmacy they were reporting from, which allowed the researchers to screen
for duplicate submissions. The second question asked the participant if their school or
college of pharmacy currently has performance enhancing drugs instruction incorporated
into their curriculum. If not, respondents were asked to comment on future offerings of
content related to performance enhancing drugs, before being exited from the survey.
For those that did indicate offering performance enhancing drugs instruction,
respondents were asked to indicate how it was offered (required course, elective course,
entire course, partial course, rotation, etc.). This question branched off into a series of
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questions asking about course names, contact hours and/or credits of performance
enhancing drugs coverage, and specific content covered related to performance
enhancing drugs in these courses. Respondents were given the opportunity to provide
qualitative comments regarding performance enhancing drugs coverage in their
respective schools or colleges.
Data Collection
University of Mississippi IRB exemption was obtained for this study before data
collection commenced. Self-administered surveys were distributed via Qualtrics®.
Qualtrics® is an internet-based survey company and potential participants were sent an
invitation to complete a survey over email in September of 2019. The invitation included
information about the study and a detailed a voluntary link to the survey. The potential
participants were also informed that their answers were confidential and the name of the
school or college they represented was only recorded to prevent duplicate data. Potential
respondents were sent two email invitations with the survey link embedded, one email
was the initial contact, and the second email was the reminder sent to those who did not
respond to the initial. Participants were invited to forward the survey to someone in their
school or college who might have better knowledge of curricular coverage of
performance enhancing drugs, than the designated curriculum coordinator.
Analysis
Simple descriptive statistics were used to tabulate data.
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RESULTS
Sample Description and Knowledge of Performance Enhancing Drugs
To have a better understanding of the characteristics and aspects of the curriculum
in the respondents’ school or college of pharmacy, several questions were asked in regard
to the coverage that their institution could possess about performance enhancing drugs.
Of the 21 completed surveys (10.6% response rate), only 20 were used as one institution
had two respondents on its behalf. The more complete response from that school or
college of pharmacy was used in the analysis of the data. Of the 20 responding schools
only 8 reported that their professional pharmacy program offers content related to
performance enhancing drugs in their PharmD curriculum. Of the 12 who reported that
their professional pharmacy program does not offer content related to performance
enhancing drugs in their PharmD curriculum, only two schools or colleges of pharmacy
reported that there are future plans for coverage of them. One of the institutions indicated
that “We discussed this once in our curriculum. However, we [are] planning on including
this as part of our discussion on hormone therapy (testosterone, etc.) this year. It will
likely be an added discussion point (15-20 minutes) or incorporated into a case.”
Embedded in Curriculum
Respondents could indicate where content related to performance enhancing
drugs is placed in their PharmD curriculum. Eight schools or colleges of pharmacy
reported (100%, n=8). 75% (n=8) reported that the content is embedded in a required
didactic course, 50% (n=8) reported that the content is offered as a stand-alone didactic
elective course, 12.5% (n=8) reported that the content is embedded in a required
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introductory or advanced pharmacy practice experience (IPPE or APPE), 0% (n=8)
reported that the content is provided as an elective introductory or advanced pharmacy
practice experience (IPPE or APPE), and 12.5% (n=8) reported other, but indicated that
the content was provided as a lecture in an elective didactic course. 37.5% (n=8) reported
that content is both embedded in a required didactic course and offered as a stand-alone
didactic elective course. 12.5% (n=8) reported that content is embedded in a required
didactic course, offered as a stand-alone didactic elective course, and embedded in a
required introductory or advanced pharmacy practice experience (IPPE or APPE).
Contact or Credit Hours
Respondents could have indicated the number of contact or credit hours
performance enhancing drugs are incorporated in their PharmD curriculum. Six schools
or colleges of pharmacy reported (75%, n=8) that content related to performance
enhancing drugs is embedded in a required didactic course. Five schools or colleges of
pharmacy responded with the approximate number of contact hours dedicated to
performance enhancing drugs. Two respondents indicated 1 contact hour, one respondent
indicated 2 contact hours, one respondent indicated 5 contact hours, and one respondent
indicated 10 contact hours.
Of the four schools or colleges of pharmacy that reported (50%, n=8) content
related to performance enhancing drugs is offered as a stand-alone didactic elective
course, four responded with the approximate number of credit hours dedicated to
performance enhancing drugs. One respondent indicated 1.5 credit hours and three
respondents indicated 2 credit hours.
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One school or college of pharmacy reported (12.5%, n=8) content related to
performance enhancing drugs offered in a required introductory or advanced pharmacy
practice experience (IPPE or APPE). The respondent indicated 5 contact hours occurred
within the experience.
Content Covered
Respondents could have indicated where the content related to performance
enhancing drugs is placed in the curriculum. Seven schools or colleges of pharmacy
reported (87.5%, n=8). 100% (n=7) reported their content is incorporated with
pharmacology, 71.4% (n=7) reported their content is incorporated with legal
implications, 71.4% (n=7) reported their content is incorporated with practice
implications, 28.6% (n=7) reported their content is incorporated with sports
organizations’ regulations, 57.1% (n=7) reported their content is incorporated with ethical
considerations, and 14.3% (n=7) reported their content is incorporated with drug testing
procedures. This table dictates the respondents’ responses in regard to the multiple
content areas their particular school or college or pharmacy covers in their curriculum.

Additional Responses and Comments
One of the follow up questions asked pertained to the name of the course with
content related to performance enhancing drugs. The responses include: PHCY 505:
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Integrated systems: Musculoskeletal (anabolic steroids), PHCY 506: Integrated systems:
CNS PSYCH (stimulants), Natural medicines, Integrated Sequence, Pharmacy Practice I
Principles of Pharmacology, Physiology III, Integrated Drug Therapy, PHCL 351: Drugs
and Human Performance, Use and Abuse of Drugs, Prescription drug abuse, and
Complementary and Alternative Medications.
Other comments made by respondents regarding their courses that include
discussions about performance enhancing drugs or the lack of them are: “Only over the
counter performance enhancing drugs, herbals, etc. are covered.,” “There may be some
discussion in individual courses and electives, but it has not been specifically mentioned
as a focus for our curriculum. We would certainly consider this to be content typically
covered in an elective,” “The elective course in which this lecture is presented is elected
in the P1 year by 90% or more of students,” “Not noted previously, but also included to
some degree in law course,” and “Interesting thought.”
Regional Differences in Offering Performance Enhancing Drug Curricula
The following three maps were created to determine if different regions of the
United States offer pharmacy curricula that includes performance enhancing drugs. The
maps were created using online map development software (“Create Custom Map:
United States”). The maps are split into the census regions of the United States (US
Census Bureau). This excludes the territories which are being used as its own entity for
purpose of these infographics.
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The reporting schools and colleges of pharmacy (n = 20) are described using the
key in regard to their location. The Northeast region of the United States includes 20% of
the respondents, the Midwest region includes 15% of the respondents, the Southern
region includes 45% of the respondents, and the Western region includes 20% of the
respondents. The territories that have schools or colleges of pharmacy includes 0% of the
respondents.

22

The reporting schools and colleges of pharmacy that indicated content related to
performance enhancing drugs within their respective PharmD curriculum according to
region are described in this map. The reporting schools and colleges of pharmacy (n=8)
that indicated content related to performance enhancing drugs within their respective
PharmD curriculum according to region are 0% in the Northeast region, 12.5% in the
Midwest region, 50% in the Southern region, and 37.5% in the Western region. *The
territories that have schools or colleges of pharmacy had 0% of the respondents overall
within the study and are included in this infographic for visualization and comparison.

23

The reporting schools and colleges of pharmacy that did not indicate content
related to performance enhancing drugs within their respective PharmD curriculum
according to region are described. The reporting schools and colleges of pharmacy
(n=12) that did not indicate content related to performance enhancing drugs within their
respective PharmD curriculum according to region are 33.3% in the Northeast region,
16.7% in the Midwest region, 41.7% in the Southern region, and 8.3% in the Western
region. *The territories that have schools or colleges of pharmacy had 0% of the
respondents overall within the study and are included in this infographic for visualization
and comparison.
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Regional Differences in Schools or Colleges of Pharmacy with Athletic Programs
The following six maps were created to determine whether the colleges and
universities that have schools and colleges of pharmacy have athletic programs and
whether or not they offer a curriculum that includes performance enhancing drugs. The
maps were created using online map development software (“Create Custom Map:
United States”). The first four maps are split into the census regions of the United States
(US Census Bureau). This excludes the territories which are being used as its own entity
for purpose of these infographics.
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The reporting schools and colleges of pharmacy that indicated content related to
performance enhancing drugs within their respective PharmD curriculum and have
intercollegiate athletic programs associated with the main institution according to region
are described. The Midwest region (n=1) has 0% of the reporting schools or colleges or
pharmacy for that region, the Southern region (n=4) has 100%, the Western region (n=3)
has 66.7%. *The territories that have schools or colleges of pharmacy had 0% of the
respondents overall within the study and are included in this infographic for visualization
and comparison. **The Northeast region has zero reporting schools or colleges of
pharmacy.
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The reporting schools and colleges of pharmacy that did not indicated content
related to performance enhancing drugs within their respective PharmD curriculum and
have intercollegiate athletic programs according to region associated with the main
institution are described. The Northeast region (n=4) has 75% of the reporting schools or
colleges of pharmacy for that region, the Midwest region (n=2) has 50%, the Southern
region (n=5) has 80%, and the Western region has (n=1) 0%. *The territories that have
schools or colleges of pharmacy had 0% of the respondents overall within the study and
are included in this infographic for visualization and comparison.
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The number of schools and colleges of pharmacy per region are shown. There are
26 schools and colleges of pharmacy in the Northeast region, 32 in the Midwest region,
55 in the Southern region, 29 in the Western region, and 1 in an U.S. territory. Also, this
does not include Lebanese American University or branch campuses across state lines
(i.e., Albany College of Pharmacy and Health Sciences-Colchester).
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The percentage of schools and colleges of pharmacy that have intercollegiate
athletic programs associated with the main institution per region are shown. In the
Northeast region 84.6% (n=26) of institutions that have a school or college of pharmacy
have Intercollegiate Athletic programs, in the Midwest region 84.4% (n=32), in the
Southern region 81.8% (n=55), in the Western region 58.6% (n=29), and in the U.S.
territories 0% (n=1). This does not include Lebanese American University or branch
campuses across state lines (i.e., Albany College of Pharmacy and Health SciencesColchester).
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This map (“Create Custom Map: United States”) indicates the number of schools
and colleges of pharmacy per state (“AACP Institutional Membership”). It does not
include Lebanese American University or branch campuses across state lines (i.e.,
Albany College of Pharmacy and Health Sciences-Colchester).
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This map (“Create Custom Map: United States”) indicates the number of schools
and colleges of pharmacy per state (“AACP Institutional Membership”) that also have
intercollegiate athletic programs associated with their respective main institutions. It does
not include Lebanese American University or branch campuses across state lines (i.e.,
Albany College of Pharmacy and Health Sciences-Colchester). Medical campuses or
graduate institutes of a larger university, college, or consortium (i.e., University of
Arkansas for Medical Sciences and University of Arkansas) are also considered separate.
Of the U.S. States and the District of Columbia, 58% (n=50) of U.S. States, have
the same number of schools and colleges of pharmacy as the amount of main institutions
within the state with intercollegiate athletic programs. When compared by region (US
Census Bureau) the Northeast region has 9 states and 66.7% (n=9) of states in that region
have the same number of schools and colleges of pharmacy as the amount of main
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institutions within the state with intercollegiate athletic programs. The Midwest region
has 12 states and 66.7% (n=12) of states, the Southern region has 16 states and 1 district
and 52.9% (n=17) of states and a district, and the Western region has 13 states and 76.9%
(n=13) of states.
Summary of Regional Maps
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DISCUSSION
The discussion of increasing the inclusion of performance enhancing drugs into
PharmD curriculum at U.S. schools and colleges of pharmacy should occur in the
immediate future. The number of individuals involved in athletics is increasing and the
substances included on the banned substance lists of the many different sports
organizations are ever changing. Therefore, the demand for pharmacists to have
knowledge and experience with performance enhancing drugs should be increasing.
Pharmacists can have a positive impact on the world of sports pharmacy if given the
opportunity to gain important knowledge when enrolled in a school or college of
pharmacy and/or multiple opportunities for Continuing Educations (CEs) related to the
subject matter. It is crucial that pharmacy schools and colleges incorporate performance
enhancing drugs into their curriculum if only to give their students a background to
increase awareness and potentially help athletes whether novice or high-level. Limited
studies exist about athletics and pharmacy. The significance of this study was to better
understand the number of U.S. schools and colleges of pharmacy that teach performance
enhancing drugs to their students and the extent of which they do so. After analyzing the
results of this study, it has been determined that while there are some schools and
colleges of pharmacy that include content related to performance enhancing drugs in their
curriculum, there are many more that have yet to do so and do not currently have future
implementation plans.
Interpretation of Results – Knowledge of Performance Enhancing Drugs
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Overall, very few schools or colleges of pharmacy across the country have
courses that include content related to performance enhancing drugs. Also, while the
majority of schools and colleges of pharmacy have intercollegiate athletics associated
with the main institution, very few, according to the data, include content of this subject
matter.
Interpretation of Results – Embedded in Curriculum
Overall, the majority of the schools and colleges of pharmacy reporting indicated
that content related to performance enhancing drugs is embedded in a required didactic
course or offered as a stand-alone didactic elective course. A percentage of the
respondents indicated that content is both embedded in a required didactic course and
offered as a stand-alone didactic elective course. Some reported that content is embedded
in IPPEs or APPEs or as a lecture in an elective didactic course. These findings indicate
that schools or colleges of pharmacy which have content related to performance
enhancing drugs embedded in their PharmD curriculum provide at least a background if
not an entire course of material.
Interpretation of Results – Contact or Credit Hours
Overall, the number of contact hours performance enhancing drugs is taught when
embedded in required didactic non stand-alone courses with material pertaining to
performance enhancing drugs is very low and ranges from 1 – 10 contact hours in total.
The number of credit hours for a stand-alone didactic elective course however is overall
between 1.5 or 2, with the majority of respondents indicating 2 which seems average as
the elective would not be required by ACPE and elective hours are decided upon by the
school of college or pharmacy itself. One school did indicate that there is content related
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to performance enhancing drugs in an IPPE or APPE for approximately 5 contact hours
within the experience which as schools or colleges of pharmacy provide multiple IPPEs
and APPEs over the course of a pharmacy student’s four years, this is very minimal time
and only makes up a very small percentage of a pharmacy student’s practical experience
time.
Interpretation of Results – Content Covered
Overall, the content covered in regard to performance enhancing drugs differs per
school or college of pharmacy with one commonality, pharmacology. Practice
implications and legal implications are the next two most common content covered in
addition to pharmacology. The respondents’ schools or colleges of pharmacy covered at
least two content areas. Two institutions cover five out of the 6 content areas asked. The
content areas asked in the survey were pharmacology, legal implications, practice
implications, sports organizations’ regulations, ethical considerations, and drug testing
procedures as these are the most inclusive areas involved in performance enhancing
drugs. Other areas could have been asked, but that is a limitation of the study.
Interpretation of Results - Regional Differences in Curricula
The highest percentage of responses came from the Southern region of the United
States. This is consistent with the proportion of schools and colleges of pharmacy in the
Southern region, as indicated on the map on page 28 of this document. While the
Southern region was more likely to indicate including content related to performance
enhancing drugs within their respective PharmD curriculum, they were also more likely
not to include this content. These results may likely be a function of the higher response
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rate from the Southern region, although the response rate is consistent with the higher
number of pharmacy schools or colleges in the Southern region.
Interpretation of Results - Athletic Programs
While the Southern region more often indicated having content related to
performance enhancing drugs within an institution’s PharmD curriculum and have
intercollegiate athletic programs associated with the main institution, they were also more
likely to indicate not to. Causal relationships cannot be drawn given the descriptive study
design employed. The results indicated this may be a function of the higher, but
proportionately appropriate rate of response from the Southern region. However, when
looking at the number of pharmacy schools and colleges in the U.S. that are associated
with a main institution that has an athletic program in general, a higher proportion is
found in the Northeast region. Further research is needed to explore the relationship
between the teaching of performance enhancing drugs in a pharmacy program and
athletic programs. There is little doubt that athletic programs can contribute to the
teaching of performance enhancing drugs in a school or college of pharmacy.
Limitations
Given the topic of this research and the way the data had to be collected, the
greatest limitation to the results of this study was the response rate. Schools and colleges
of pharmacy curriculum coordinators, administers, and professors are extremely busy
year-round and may not have had the time to respond to the survey. Some might have
been unsure who to forward the survey email to, some might not have seen the survey
email, and others might have had the survey email go directly into their spam inbox.
Another limitation may have been the lack of discussion of performance enhancing
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supplements or stimulants within the survey or the introduction to the survey. Both were
instead included under the title performance enhancing drugs without enough regard to
knowledge level. A second limitation involving the survey included not specifying more
content areas that could potentially have been covered by the courses. Given the low
response rate, results should be interpreted with caution and cannot be generalized to
pharmacy schools or colleges throughout the country.
Future Research
This study focused solely on whether U.S. schools and colleges of pharmacy
taught content related to performance enhancing drugs by surveying their curricular
coordinators. Future research could expand on these findings and determine whether
students at different schools and colleges of pharmacy would be interested in learning
about the subject. This could also potentially influence the addition of performance
enhancing drugs into the PharmD curriculum. Future research could also be done, as
previously stated, on the relationship between the teaching of performance enhancing
drugs in a pharmacy program and athletic programs.
Study Implications
Although there are few schools or colleges of pharmacy who offer courses about
performance enhancing drugs, the findings of the study indicate that institutions may not
realize the benefit of such courses due to the lack of current relevant information or of a
true job market in the United States for sports pharmacists. As the majority of institutions
with schools or colleges of pharmacy have intercollegiate athletic programs associated
with the main institution, but do not offer courses with content about performance
enhancing drugs it is evident that the students are not taught such content that pertains to
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the immediate vicinity. Also, to increase pharmacist involvement in sports, athletes need
to be aware that pharmacists are the drug experts and can help meet difficult organization
guidelines.
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APPENDIX 1: SURVEY
Dear Curriculum Coordinator:
My name is Sara D. Green, and I am a rising first-year pharmacy student at The
University of Mississippi. I am asking for your participation in a research survey that I
am conducting through the Sally McDonnell Barksdale Honors College. This survey
should take no more than 5-6 minutes of your time. It includes various questions about
your curricular coverage of performance enhancing drugs in your professional program
(PharmD). If you would like to forward this survey on to someone in your school more
knowledgeable about this topic, please feel free to do so. Your willingness to participate
in this research will help me better understand the depth of knowledge that students in
pharmacy schools have about performance enhancing drugs.
Please keep in mind that your participation in this survey is entirely voluntary. Your
responses will remain confidential. The purpose of asking the school for which you are
reporting in the survey is to ensure that there are no duplicates for your school. Data will
be reported in aggregate only, and no school names will be reported.
This study has been reviewed by the University of Mississippi’s Institutional Review
Board (IRB). If you have any questions, please contact the IRB at (662) 915-7482.
If you have any questions about the research project specifically, feel free to contact me
at sdgreen1@go.olemiss.edu, or my advisor, Dr. Erin Holmes, at erholmes@olemiss.edu,
or (662) 915-5914.
Thank you in advance for your participation.
Sincerely,
Sara D. Green
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